AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-77
Results: 1-25/77
ANALYSIS OF LOSS OF HETEROZYGOSITY IN 399 PREMALIGNANT BREAST-LESIONSAT 15 GENETIC-LOCI
Authors: OCONNELL P PEKKEL V FUQUA SAW OSBORNE CK CLARK GM ALLRED DC
Citation: P. Oconnell et al., ANALYSIS OF LOSS OF HETEROZYGOSITY IN 399 PREMALIGNANT BREAST-LESIONSAT 15 GENETIC-LOCI, Journal of the National Cancer Institute, 90(9), 1998, pp. 697-703
HEAT-SHOCK PROTEINS HSP27 AND HSP70 - LACK OF CORRELATION WITH RESPONSE TO TAMOXIFEN AND CLINICAL COURSE OF DISEASE IN ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER (A SOUTHWEST-ONCOLOGY-GROUP STUDY)
Authors: CIOCCA DR GREEN S ELLEDGE RM CLARK GM PUGH R RAVDIN P LEW D MARTINO S OSBORNE CK
Citation: Dr. Ciocca et al., HEAT-SHOCK PROTEINS HSP27 AND HSP70 - LACK OF CORRELATION WITH RESPONSE TO TAMOXIFEN AND CLINICAL COURSE OF DISEASE IN ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER (A SOUTHWEST-ONCOLOGY-GROUP STUDY), Clinical cancer research, 4(5), 1998, pp. 1263-1266
HEAT-SHOCK PROTEINS HSP27 AND HSP70 - LACK OF CORRELATION WITH RESPONSE TO TAMOXIFEN AND CLINICAL COURSE OF DISEASE IN ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER (A SOUTHWEST-ONCOLOGY-GROUP STUDY)
Authors: CIOCCA DR GREEN S ELLEDGE RM CLARK GM PUGH R RAVDIN P LEW D MARTINO S OSBORNE CK
Citation: Dr. Ciocca et al., HEAT-SHOCK PROTEINS HSP27 AND HSP70 - LACK OF CORRELATION WITH RESPONSE TO TAMOXIFEN AND CLINICAL COURSE OF DISEASE IN ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER (A SOUTHWEST-ONCOLOGY-GROUP STUDY), Clinical cancer research, 4(5), 1998, pp. 1263-1266
HER-2 EXPRESSION AND RESPONSE TO TAMOXIFEN IN ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: ELLEDGE RM GREEN S CIOCCA D PUGH R ALLRED DC CLARK GM HILL J RAVDIN P OSULLIVAN J MARTINO S OSBORNE CK
Citation: Rm. Elledge et al., HER-2 EXPRESSION AND RESPONSE TO TAMOXIFEN IN ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Clinical cancer research, 4(1), 1998, pp. 7-12
HER-2 EXPRESSION AND RESPONSE TO TAMOXIFEN IN ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: ELLEDGE RM GREEN S CIOCCA D PUGH R ALLRED DC CLARK GM HILL J RAVDIN P OSULLIVAN J MARTINO S OSBORNE CK
Citation: Rm. Elledge et al., HER-2 EXPRESSION AND RESPONSE TO TAMOXIFEN IN ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Clinical cancer research, 4(1), 1998, pp. 7-12
BREAST-CANCER CLINICAL-TRIALS WITH FASLODEX - A NEW CLASS OF ANTIESTROGEN
Authors: HOWELL A OSBORNE CK MORRIS CQ DIMERY I
Citation: A. Howell et al., BREAST-CANCER CLINICAL-TRIALS WITH FASLODEX - A NEW CLASS OF ANTIESTROGEN, European journal of cancer, 34, 1998, pp. 74-74
MOLECULAR TARGETS IN BREAST-CANCER PREVENTION
Authors: OSBORNE CK
Citation: Ck. Osborne, MOLECULAR TARGETS IN BREAST-CANCER PREVENTION, Annals of oncology, 9, 1998, pp. 2-2
16-WEEK MULTIDRUG REGIMEN VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND FLUOROURACIL AS ADJUVANT THERAPY FOR NODE-POSITIVE, RECEPTOR-NEGATIVE BREAST-CANCER - AN INTERGROUP STUDY
Authors: FETTING JH GRAY R FAIRCLOUGH DL SMITH TJ MARGOLIN KA CITRON ML GROVECONRAD M CELLA D PANDYA K ROBERT N HENDERSON IC OSBORNE CK ABELOFF MD
Citation: Jh. Fetting et al., 16-WEEK MULTIDRUG REGIMEN VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND FLUOROURACIL AS ADJUVANT THERAPY FOR NODE-POSITIVE, RECEPTOR-NEGATIVE BREAST-CANCER - AN INTERGROUP STUDY, Journal of clinical oncology, 16(7), 1998, pp. 2382-2391
RADIATION-THERAPY AND SURVIVAL IN BREAST-CANCER PATIENTS WITH 10 OR MORE POSITIVE AXILLARY LYMPH-NODES TREATED WITH MASTECTOMY
Authors: DIAB SG HILSENBECK SG DEMOOR C CLARK GM OSBORNE CK RAVDIN PM ELLEDGE RM
Citation: Sg. Diab et al., RADIATION-THERAPY AND SURVIVAL IN BREAST-CANCER PATIENTS WITH 10 OR MORE POSITIVE AXILLARY LYMPH-NODES TREATED WITH MASTECTOMY, Journal of clinical oncology, 16(5), 1998, pp. 1655-1660
EASTERN-COOPERATIVE-ONCOLOGY-GROUP RANDOMIZED TRIALS OF OBSERVATION VERSUS MAINTENANCE THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER IN COMPLETE REMISSION FOLLOWING INDUCTION TREATMENT
Authors: FALKSON G GELMAN RS PANDYA KJ OSBORNE CK TORMEY D CUMMINGS FJ SLEDGE GW ABELOFF MD
Citation: G. Falkson et al., EASTERN-COOPERATIVE-ONCOLOGY-GROUP RANDOMIZED TRIALS OF OBSERVATION VERSUS MAINTENANCE THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER IN COMPLETE REMISSION FOLLOWING INDUCTION TREATMENT, Journal of clinical oncology, 16(5), 1998, pp. 1669-1676
A MULTICENTER RANDOMIZED CLINICAL-TRIAL OF GOSERELIN VERSUS SURGICAL OVARIECTOMY IN PREMENOPAUSAL PATIENTS WITH RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - AN INTERGROUP STUDY
Authors: TAYLOR CW GREEN S DALTON WS MARTINO S RECTOR D INGLE JN ROBERT NJ BUDD GT PARADELO JC NATALE RB BEARDEN JD MAILLIARD JA OSBORNE CK
Citation: Cw. Taylor et al., A MULTICENTER RANDOMIZED CLINICAL-TRIAL OF GOSERELIN VERSUS SURGICAL OVARIECTOMY IN PREMENOPAUSAL PATIENTS WITH RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - AN INTERGROUP STUDY, Journal of clinical oncology, 16(3), 1998, pp. 994-999
SURVIVAL ADVANTAGE OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK NODE-NEGATIVE BREAST-CANCER - 10-YEAR ANALYSIS - AN INTERGROUP STUDY
Authors: MANSOUR EG GRAY R SHATILA AH TORMEY DC COOPER MR OSBORNE CK FALKSON G
Citation: Eg. Mansour et al., SURVIVAL ADVANTAGE OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK NODE-NEGATIVE BREAST-CANCER - 10-YEAR ANALYSIS - AN INTERGROUP STUDY, Journal of clinical oncology, 16(11), 1998, pp. 3486-3492
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
DRUG-THERAPY - TAMOXIFEN IN THE TREATMENT OF BREAST-CANCER
Authors: OSBORNE CK
Citation: Ck. Osborne, DRUG-THERAPY - TAMOXIFEN IN THE TREATMENT OF BREAST-CANCER, The New England journal of medicine, 339(22), 1998, pp. 1609-1618
DIVERSE SIGNALING PATHWAYS MODULATE NUCLEAR RECEPTOR RECRUITMENT OF N-COR AND SMRT COMPLEXES
Authors: LAVINSKY RM JEPSEN K HEINZEL T TORCHIA J MULLEN TM SCHIFF R DELRIO AL RICOTE M NGO S GEMSCH J HILSENBECK SG OSBORNE CK GLASS CK ROSENFELD MG ROSE DW
Citation: Rm. Lavinsky et al., DIVERSE SIGNALING PATHWAYS MODULATE NUCLEAR RECEPTOR RECRUITMENT OF N-COR AND SMRT COMPLEXES, Proceedings of the National Academy of Sciences of the United Statesof America, 95(6), 1998, pp. 2920-2925
BCL-2 AND APOPTOSIS IN LYMPH-NODE POSITIVE BREAST-CARCINOMA
Authors: BERARDO MD ELLEDGE RM DEMOOR C CLARK GM OSBORNE CK ALLRED DC
Citation: Md. Berardo et al., BCL-2 AND APOPTOSIS IN LYMPH-NODE POSITIVE BREAST-CARCINOMA, Cancer, 82(7), 1998, pp. 1296-1302
TELOMERASE ACTIVITY AND SURVIVAL OF PATIENTS WITH NODE-POSITIVE BREAST-CANCER
Authors: CLARK GM OSBORNE CK LEVITT D WU F KIM NW
Citation: Gm. Clark et al., TELOMERASE ACTIVITY AND SURVIVAL OF PATIENTS WITH NODE-POSITIVE BREAST-CANCER, Journal of the National Cancer Institute, 89(24), 1997, pp. 1874-1881
PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOENDOCRINE THERAPY IN PRIMARY BREAST CARCINOMAS
Authors: MAKRIS A POWLES TJ DOWSETT M OSBORNE CK TROTT PA FERNANDO IN ASHLEY SE ORMEROD MG TITLEY JC GREGORY RK ALLRED DC
Citation: A. Makris et al., PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOENDOCRINE THERAPY IN PRIMARY BREAST CARCINOMAS, Clinical cancer research, 3(4), 1997, pp. 593-600
ESTROGEN-RECEPTORS AND BREAST-CANCER - IT IS TIME FOR INDIVIDUALIZED TREATMENT BASED ON ESTROGEN-RECEPTOR STATUS
Authors: ELLEDGE RM OSBORNE CK
Citation: Rm. Elledge et Ck. Osborne, ESTROGEN-RECEPTORS AND BREAST-CANCER - IT IS TIME FOR INDIVIDUALIZED TREATMENT BASED ON ESTROGEN-RECEPTOR STATUS, BMJ. British medical journal, 314(7098), 1997, pp. 1843-1844
POLYETHYLENE-GLYCOL CONJUGATED INSULIN-LIKE-GROWTH-FACTOR BINDING PROTEIN-1 (IGFBP-1) INHIBITS GROWTH OF BREAST-CANCER IN ATHYMIC MICE
Authors: VANDENBERG CL COX GN STROH CA HILSENBECK SG WENG CN MCDERMOTT MJ PRATT D OSBORNE CK CORONADOHEINSOHN EB YEE D
Citation: Cl. Vandenberg et al., POLYETHYLENE-GLYCOL CONJUGATED INSULIN-LIKE-GROWTH-FACTOR BINDING PROTEIN-1 (IGFBP-1) INHIBITS GROWTH OF BREAST-CANCER IN ATHYMIC MICE, European journal of cancer, 33(7), 1997, pp. 1108-1113
MEGESTROL-ACETATE AND AMINOGLUTETHIMIDE HYDROCORTISONE IN SEQUENCE ORIN COMBINATION AS 2ND-LINE ENDOCRINE THERAPY OF ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP PHASE-III TRIAL/
Authors: RUSSELL CA GREEN SJ OSULLIVAN J HYNES HE BUDD GT CONGDON JE MARTINO S OSBORNE CK
Citation: Ca. Russell et al., MEGESTROL-ACETATE AND AMINOGLUTETHIMIDE HYDROCORTISONE IN SEQUENCE ORIN COMBINATION AS 2ND-LINE ENDOCRINE THERAPY OF ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP PHASE-III TRIAL/, Journal of clinical oncology, 15(7), 1997, pp. 2494-2501
BCL-2, P53, AND RESPONSE TO TAMOXIFEN IN ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: ELLEDGE RM GREEN S HOWES L CLARK GM BERARDO M ALLRED DC PUGH R CIOCCA D RAVDIN P OSULLIVAN J RIVKIN S MARTINO S OSBORNE CK
Citation: Rm. Elledge et al., BCL-2, P53, AND RESPONSE TO TAMOXIFEN IN ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(5), 1997, pp. 1916-1922
CYTOLOGICAL EVALUATION OF BIOLOGICAL PROGNOSTIC MARKERS FROM PRIMARY BREAST CARCINOMAS
Authors: MAKRIS A ALLRED DC POWLES TJ DOWSETT M FERNANDO IN TROTT PA ASHLEY SE ORMEROD MG TITLEY JC OSBORNE CK
Citation: A. Makris et al., CYTOLOGICAL EVALUATION OF BIOLOGICAL PROGNOSTIC MARKERS FROM PRIMARY BREAST CARCINOMAS, Breast cancer research and treatment, 44(1), 1997, pp. 65-74
PROGNOSTIC-SIGNIFICANCE OF PAI-1 AND UPA IN CYTOSOLIC EXTRACTS OBTAINED FROM NODE-POSITIVE BREAST-CANCER PATIENTS
Authors: GRONDAHLHANSEN J HILSENBECK SG CHRISTENSEN IJ CLARK GM OSBORNE CK BRUNNER N
Citation: J. Grondahlhansen et al., PROGNOSTIC-SIGNIFICANCE OF PAI-1 AND UPA IN CYTOSOLIC EXTRACTS OBTAINED FROM NODE-POSITIVE BREAST-CANCER PATIENTS, Breast cancer research and treatment, 43(2), 1997, pp. 153-163
MITOSIN (A NEW PROLIFERATION MARKER) CORRELATES WITH CLINICAL OUTCOMEIN NODE-NEGATIVE BREAST-CANCER
Authors: ALLRED DC CLARK GM HILSENBECK SG OSBORNE CK LEE WH
Citation: Dc. Allred et al., MITOSIN (A NEW PROLIFERATION MARKER) CORRELATES WITH CLINICAL OUTCOMEIN NODE-NEGATIVE BREAST-CANCER, Laboratory investigation, 76(1), 1997, pp. 69-69
Risultati: 1-25 | 26-50 | 51-75 | 76-77